The underlying mechanism is that TPM is a class II tumor-suppressor gene, and its gene sequence structure is complete, but its expression is insufficient or not expressed due to downregulation or silencing in transcription or translation [80]. The gene discussed is ENSG00000280371; the disease is neoplasm.